Adams Clinical, Boston

Boston, Massachusetts 02116

13 studies enrolling now · 18 studies all time

What they study most

Alcohol Use Disorder, Alzheimer Disease, Alzheimer Disease Due to P. Gingivalis, Alzheimer's Disease, Alzheimers Disease, Borderline Personality Disorder, Depressive Disorder, Major, Generalized Anxiety Disorder, Major Depressive Disorder, Opioid Use Disorder

Studies at this site

• A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend) — Recruiting now
• Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease — Recruiting now
• A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease — Recruiting now
• A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder — Recruiting now
• A Study of Brenipatide in Participants With Alcohol Use Disorder — Recruiting now
• A Study of Brenipatide in Adult Participants With Major Depressive Disorder — Recruiting now
• A Study of Brenipatide in Participants With Opioid Use Disorder — Recruiting now
• A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3) — Recruiting now
• A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder — Recruiting now
• Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies — Recruiting now
• "A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder" — Recruiting now
• Triage Survey for Psychiatry Research Eligibility — Recruiting now
• A Phase 3 Trial of DT120 for Major Depressive Disorder (Emerge) — Running, not enrolling
• A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Panorama) — Running, not enrolling
• An Open-Label Study of Azetukalner in Major Depressive Disorder — Enrolling by invitation
• Phase III Long-term Extension Trial to Assess Safety and Efficacy of CYB003 in MDD (EXTEND) — Enrolling by invitation
• A Phase 3 Trial of DT120 for Generalized Anxiety Disorder (Voyage) — Running, not enrolling
• A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3) — Running, not enrolling